Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer - The Movsas article reviewed

被引：0
|
作者：
Wagner, H [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33682 USA
来源：
ONCOLOGY-NEW YORK | 2002年 / 16卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：105 / 106
页数：2
相关论文
共 50 条
  • [1] Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer
    Movsas, B
    [J]. ONCOLOGY-NEW YORK, 2002, 16 (01): : 90 - +
  • [2] Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer - Part 1
    Movsas, B
    [J]. ONCOLOGY-NEW YORK, 2001, 15 (12): : 1549 - 1558
  • [3] A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer.
    Keller, SM
    Adak, S
    Wagner, H
    Herskovic, A
    Komaki, R
    Brooks, BJ
    Perry, MC
    Livingston, RB
    Johnson, DH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (17): : 1217 - 1222
  • [4] Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer
    Scagliotti, GV
    Fossati, R
    Torri, V
    Crinó, L
    Giaccone, G
    Silvano, G
    Martelli, M
    Clerici, M
    Cognetti, F
    Tonato, M
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (19) : 1453 - 1461
  • [5] Resected non-small-cell lung cancer stage I/II: Indication for adjuvant/neoadjuvant therapy?
    Hoffmann, H
    [J]. LUNG CANCER, 2004, 45 : S91 - S97
  • [6] Adjuvant therapy of resected non-small-cell lung cancer
    Keller, SM
    [J]. CURRENT OPINION IN ONCOLOGY, 2000, 12 (02) : 149 - 155
  • [7] Postoperative adjuvant therapy for stage II non-small-cell lung cancer
    Park, JH
    Shim, YM
    Baek, HJ
    Kim, MS
    Choe, DH
    Cho, KJ
    Lee, CT
    Zo, JI
    [J]. ANNALS OF THORACIC SURGERY, 1999, 68 (05): : 1821 - 1826
  • [8] Adjuvant therapy in completely resected non-small-cell lung cancer
    Giorgio V. Scagliotti
    Silvia Novello
    [J]. Current Oncology Reports, 2003, 5 (4) : 318 - 325
  • [9] Optimal Adjuvant Therapy in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer Harboring EGFR Mutations
    Wen, Miaomiao
    Wang, Lei
    Wang, Xuejiao
    Yang, Sanhu
    Sun, Ying
    Xia, Jinghua
    Zhang, Yanning
    Zhang, Zhipei
    Huang, Lijun
    Jiang, Tao
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (12) : 686 - 693
  • [10] Multimodality therapy in stage IIIA non-small-cell lung cancer
    Kim, SY
    Lee, YS
    Jung, SS
    Yun, WJ
    Kim, JO
    Cho, MJ
    Lim, SR
    Kim, JS
    Roh, YH
    [J]. LUNG CANCER, 2004, 45 : S57 - S58
12345